Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease
The COVID-19 pandemic prompted several drug repositioning initiatives with the aim to rapidly deliver pharmacological candidates able to reduce SARSCoV- 2 dissemination and mortality. A major issue shared by many of the in silico studies addressing the discovery of compounds or drugs targeting SARS-...
Guardado en:
| Autores principales: | Prada Gori, Denis Nihuel, Ruatta, Santiago, Fló, Martín, Alberca, Lucas Nicolás, Bellera, Carolina Leticia, Park, Soonju, Heo, Jinyeong, Lee, Honggun, Paul Park, Kyu-Ho, Pritsch, Otto, Shum, David, Comini, Marcelo A., Talevi, Alan |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2023
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/152249 |
| Aporte de: |
Ejemplares similares
-
In <i>silico</i> Guided Drug Repurposing : Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2
por: Alberca, Lucas Nicolás, et al.
Publicado: (2019) -
How Can Network-Pharmacology Contribute to Antiepileptic Drug Development?
por: Di Ianni, Mauricio Emiliano, et al.
Publicado: (2014) -
Identification of levothyroxine antichagasic activity through computer-aided drug repurposing
por: Bellera, Carolina Leticia, et al.
Publicado: (2014) -
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases
por: Berenstein, A.J., et al. -
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases
Publicado: (2016)